ID   31E9
AC   CVCL_7238
DR   CLO; CLO_0001292
DR   ATCC; HB-11052
DR   CCRID; 4201PAT-CCTCC00112
DR   Wikidata; Q54584739
RX   Patent=US5565338;
RX   Patent=US5723582;
RX   Patent=WO1994026923A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11052.
CC   Characteristics: T-cell hybridoma. Produces MIF.
CC   Monoclonal antibody target: Japanese cedar pollen antigen.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G691 ! BUC
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
RX   Patent=US5565338;
RA   Ishizaka K.;
RT   "Suppressor T-cell hybridoma and production of allergen specific
RT   glycosylation inhibiting factor.";
RL   Patent number US5565338, 15-Oct-1996.
//
RX   Patent=US5723582;
RA   Ishizaka K.;
RT   "Antigen-specific human glycosylation inhibiting factor.";
RL   Patent number US5723582, 03-Mar-1998.
//
RX   Patent=WO1994026923A1;
RA   Ishizaka K., Liu Y.-C., Mikayama T.;
RT   "Method for recombinant production of biologically active
RT   polypeptides.";
RL   Patent number WO1994026923A1, 24-Nov-1994.
//